Twist Bioscience Corporation
TWST
$29.70
-$0.16-0.54%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 20.32% | 22.72% | 25.30% | 25.85% | 27.69% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 20.32% | 22.72% | 25.30% | 25.85% | 27.69% |
| Cost of Revenue | 3.31% | 4.73% | 8.22% | 8.60% | 15.60% |
| Gross Profit | 43.24% | 49.12% | 52.80% | 56.81% | 48.61% |
| SG&A Expenses | 13.08% | 11.15% | 13.81% | 10.73% | 15.11% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.90% | 4.77% | 7.52% | 5.62% | 8.16% |
| Operating Income | 22.54% | 23.65% | 18.27% | 20.26% | 14.98% |
| Income Before Tax | 63.03% | 61.42% | 0.26% | 3.83% | -2.31% |
| Income Tax Expenses | 28.57% | -15.44% | -57.57% | -55.10% | -51.39% |
| Earnings from Continuing Operations | 62.79% | 61.33% | 0.52% | 4.13% | -2.01% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 62.79% | 61.33% | 0.52% | 4.13% | -2.01% |
| EBIT | 22.54% | 23.65% | 18.27% | 20.26% | 14.98% |
| EBITDA | 22.28% | 22.48% | 17.34% | 21.46% | 17.61% |
| EPS Basic | 63.81% | 62.11% | 2.75% | 6.07% | -0.07% |
| Normalized Basic EPS | 25.27% | 24.21% | 19.05% | 21.84% | 17.10% |
| EPS Diluted | 63.55% | 61.82% | 2.71% | 6.03% | -0.10% |
| Normalized Diluted EPS | 25.60% | 24.52% | 19.05% | 21.84% | 17.10% |
| Average Basic Shares Outstanding | 3.13% | 2.89% | 2.58% | 2.21% | 1.95% |
| Average Diluted Shares Outstanding | 3.63% | 3.39% | 2.58% | 2.21% | 1.95% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |